An Executive Summary A successful product launch begins long before FDA approval. Commercialization is not a single event—it is a series of strategic decisions that determine whether an innovative therapy can successfully reach patients while creating long-term value for the company. Over more than 30 years in pharmaceutical and biotechnology commercialization, I have found that successful organizations consistently follow the same fundamental principles.
Full article
Full article available by request only.
Contact PharmaKonsult to request the complete opinion paper.